**Core Concept**
Chronic atrial fibrillation requires management to prevent thromboembolic events, control heart rate, and improve symptoms. The primary goal is to restore sinus rhythm, but in many cases, rate control is the preferred strategy, especially in patients with heart failure or significant comorbidities.

**Why the Correct Answer is Right**
The medication of choice for rate control in chronic atrial fibrillation is beta-blockers. These drugs reduce the sympathetic tone on the heart, decrease the heart rate, and prolong the atrioventricular (AV) node refractory period. This results in a more stable and controlled heart rate, which is particularly beneficial in patients with chronic atrial fibrillation. Beta-blockers, such as metoprolol, bisoprolol, or carvedilol, are often prescribed as first-line therapy due to their efficacy and safety profile.

**Why Each Wrong Option is Incorrect**
**Option A:** Digoxin is not the first-line treatment for chronic atrial fibrillation. While it can be used for rate control, its efficacy is limited, and it has a narrow therapeutic index, making it less suitable for long-term management.
**Option B:** Calcium channel blockers, such as diltiazem or verapamil, can be used for rate control but are generally not the first choice due to their potential to worsen heart failure and increase the risk of hypotension.
**Option C:** Amiodarone is an antiarrhythmic medication that can be used to restore sinus rhythm in some patients with atrial fibrillation. However, it is not typically prescribed for rate control and is associated with significant side effects, making it a less favorable option for chronic management.

**Clinical Pearl / High-Yield Fact**
In patients with chronic atrial fibrillation, the use of beta-blockers is associated with a reduced risk of stroke and mortality. Always consider the patient's heart failure status, comorbidities, and potential drug interactions when selecting a medication for rate control.

**Correct Answer: C. Amiodarone is an antiarrhythmic medication that can be used to restore sinus rhythm in some patients with atrial fibrillation. However, it is not typically prescribed for rate control and is associated with significant side effects, making it a less favorable option for chronic management.